These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 39080260

  • 21. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
    Zhao Y, Gao J, Xie X, Nan P, Liu F, Sun Y, Zhao X.
    Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. TKTL1 promotes cell proliferation and metastasis in esophageal squamous cell carcinoma.
    Li J, Zhu SC, Li SG, Zhao Y, Xu JR, Song CY.
    Biomed Pharmacother; 2015 Aug; 74():71-6. PubMed ID: 26349965
    [Abstract] [Full Text] [Related]

  • 24. CPSF3 regulates alternative polyadenylation of CNIH2 to promote esophageal squamous cell carcinoma progression.
    Zhang Y, Liu D, Guo D, Lin W, Lu W, Hu L, Chen S, Chen C.
    Cancer Lett; 2024 Jul 01; 593():216925. PubMed ID: 38718887
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
    Wang G, Feng B, Niu Y, Wu J, Yang Y, Shen S, Guo Y, Liang J, Guo W, Dong Z.
    Mol Carcinog; 2020 Dec 01; 59(12):1392-1408. PubMed ID: 33079409
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma.
    Tao M, Luo J, Gu T, Yu X, Song Z, Jun Y, Gu H, Han K, Huang X, Yu W, Sun S, Zhang Z, Liu L, Chen X, Zhang L, Luo C, Wang Q.
    Cell Death Dis; 2021 Sep 13; 12(9):845. PubMed ID: 34518524
    [Abstract] [Full Text] [Related]

  • 38. IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma.
    Hu J, Dai C, Ding Z, Pan Y, Lu L, Bao J, Zheng J.
    BMC Cancer; 2024 Jun 24; 24(1):759. PubMed ID: 38914958
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. S100A11 activates the pentose phosphate pathway to induce malignant biological behaviour of pancreatic ductal adenocarcinoma.
    Zeng X, Guo H, Liu Z, Qin Z, Cong Y, Ren N, Zhang Y, Zhang N.
    Cell Death Dis; 2022 Jun 25; 13(6):568. PubMed ID: 35752610
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.